This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma - Contacts and Locations

Home Search Study Topics Glossary

This is a Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients With Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00639002. Last updated on January 8, 2009.

Information provided by Incyte Corporation

Please refer to this study by its ClinicalTrials.gov identifier: NCT00639002

Locations

United States, California

Highland, California, United States, 92346
United States, Florida

Boynton Beach, Florida, United States, 33435
United States, New York

New York, New York, United States, 10011

Sponsors and Collaborators

Incyte Corporation

Investigators

Principal Investigator:

Sundar Jagannath, MD

St. Vincent's Comprehensive Cancer Center, New York, New York